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Cytoskeleton, the internal scaffold of the cell, displays an
exceptional combination of stability and dynamics. It is
composed of three major filamentous networks, microfi-
laments (actin filaments), intermediate filaments (neurofi-
laments), and microtubules. Together, they ensure the
physical and structural stability of the cell, whereby also
mediating its large-scale structural rearrangements, motil-
ity, stress response, division, and internal transport. All
three cytoskeletal systems are built upon the same basic
design: they have a central repetitive scaffold assembled
from folded building elements, surrounded and regulated
by accessory regions/proteins that regulate its formation
and mediate its countless interactions with its environ-
ment, serving to send regulatory signals to and from the
cytoskeleton. Here, we elaborate on the idea that the
opposing features of stability and dynamics are also man-
ifest in the dichotomy of the structural status of its com-
ponents, the core being highly structured and the
accessory proteins/regions being highly disordered, and
are responsible for most of the regulatory (post-transla-
tional) input promoting adaptive responses and provid-
ing dynamics necessary for each of the cytoskeletal
systems. This pattern entails special consequences, in
which the manifold functional advantages of structural
disorder, most pronounced in regulatory and signaling
functions, are all exploited by nature. VC 2013 Wiley Periodicals, Inc.
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Introduction
The cytoskeleton is composed of three basic compo-nents: microfilaments (actin), intermediate filaments
[neurofilaments (NFs) in neuronal cells], and microtubules
(MTs), and it provides the internal scaffold (skeleton) of
the cell. It can be considered as a very special organelle,
which represents a unique combination of stability and
dynamics, physical rigidity and flexibility, long-time per-
sistence and rapid, cataclysmic rearrangements. By provid-
ing a special microenvironment, the cytoskeleton ensures
the physical separation of cellular constituents, thus segre-
gating and directing cellular activities. It bridges molecular
(nano-m) and cellular (micro-m) distances and represent
the tracks of transport of cellular constituents over large
distances. It provides the locomotive force of cell migra-
tion, it drives clustering of membrane proteins, drives cell
division and the formation of protrusions the cell uses for
exploring its environment. Apparently it does it by a com-
bination of a physically rigid but inherently unstable cen-
tral scaffold and a flexible and rather variable outer layer
of accessory proteins/regions. Due to its central impor-
tance in cell physiology, the cytoskeleton is involved in
many diseases, ranging from cancer to neurodegeneration
[Pajkos et al., 2012; Raychaudhuri et al., 2009; Uversky
et al., 2008]. Our central theme here is that multifaceted
and highly dynamic behavior is enabled by structural dis-
order in all three major cytoskeletal constituents, also
reflecting their increasing complexity from NFs to the
actin cytoskeleton (Supporting Information Table S1,
Table I). Intermediate filaments (IFs) have three principal
components, IF-L(ight), IF-M(edium), and IF-H(igh), all
three of which form an extended coiled-coil structures,
from which their variable disordered tails project away
[Fuchs and Weber, 1994; Fuchs and Cleveland, 1998].
MTs are hollow tubes of protofilaments, made up of vir-
tual filaments of polymerized tubulin a/b heterodimers.
Their stability and interactions with their environment
depend on the presence and association of fully disordered
accessory proteins, such as microtubule-associated protein
2 (MAP2), tau protein, and stathmin [Alexa et al., 2002;
Cassimeris, 2002; Dehmelt and Halpain, 2005]. The
most diverse and versatile component of the cytoskeleton
is microfilaments, which contain filamentous actin
(F-actin) regulated in diverse ways by largely disordered
accessory/regulatory proteins (e.g., Tb4 and Wiskott–
Aldrich syndrome protein [WASP]).
Additional Supporting Information may be found in the online
version of this article.
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The likely importance of structural disorder in all three
systems results from the special functional modes it permits.
For many proteins, termed intrinsically disordered pro-
teins/regions (IDP/IDR), the entire protein or its segment
lacks a well-defined tertiary structure, rather it exists in an
unfolded state with no tertiary and only transient secondary
structural contacts. This dynamic structural ensemble is
maintained by the highly hydrophilic nature of their poly-
peptide chain [Uversky et al., 2000]. The most comprehen-
sive repository of IDPs/IDRs, the DisProt database
[Sickmeier et al., 2007], holds about 1500 disordered
regions within about 700 proteins. Structural disorder is
typically higher in eukaryotes (5–15% of proteins are fully
disordered and about 50% have at least one long disordered
region) than in prokaryotes [Burra et al., 2010; Pancsa and
Tompa, 2012]. Structural disorder abounds in functional cat-
egories associated with signal transduction, regulation of tran-
scription, and chromatin organization [Tompa and Csermely,
2004; Ward et al., 2004; Xie et al., 2007]. There are two
basic modes of action of IDPs/IDRs, their function either
stems directly from their disorder (entropic chains, e.g., link-
ers, entropic bristles, etc.) or from molecular recognition/
interaction (e.g., binding their partner via short recognition
elements [Davey et al., 2006; Diella et al., 2008] or disor-
dered domains [Tompa et al., 2009] in a process of induced
folding [Wright and Dyson, 2009]). The functional outcome
in both types of functions is different from the action of
folded proteins. Entropic chain functional modes are not
accessible to folded proteins, whereas in recognition functions
structural disorder may uncouple specificity from binding
strength, enable adaptability to different binding partners
[Davey et al., 2011; Huang and Liu, 2013; Tompa et al.,
2005] often effectively regulated by post-translational modifi-
cations [Iakoucheva et al., 2004], and mediate interactions
with multiple partners as hubs in protein–protein interaction
networks [Dosztanyi et al., 2006; Hegyi et al., 2007].
In a sense, the field of structural disorder is still in its
infancy, and much work is needed to bring it to the descrip-
tive and predictive level of classical structural biology, so as
to deserve the term “unstructural” biology [Tompa, 2011].
The characterization of structural disorder is usually
achieved by two complementary approaches. Bioinfor-
matics predictions of structural disorder is now based on a
variety of principles, such as amino acid propensity
[Prilusky et al., 2005; Uversky et al., 2000], secondary
structure preference [Liu and Rost, 2003], contact poten-
tials of amino acids [Dosztanyi et al., 2005; Schlessinger
et al., 2007], or more complex relationships between
sequence and disorder, captured by machine learning algo-
rithms [Peng et al., 2005] or meta-approaches [Ishida and
Kinoshita, 2008; Schlessinger et al., 2009]. The ever-
increasing accuracy and dependability [Monastyrskyy et al.,
2011] of these approaches positioned bioinformatics in the
center of addressing questions at the genome/proteome
level, such as the phylogenetic distribution of disorder
[Pancsa and Tompa, 2012; Xue et al., 2010], its correlation
with different functional categories [Ward et al., 2004] and
involvement in disease [Hegyi et al., 2009; Iakoucheva
et al., 2002; Pajkos et al., 2012]. Bioinformatics can also
outline functional elements in individual disordered pro-
teins, such as short binding motifs [Davey et al., 2006; Fux-
reiter et al., 2007], post-translational modification sites
[Iakoucheva et al., 2004], and sites of protein–protein inter-
actions [Dosztanyi et al., 2009].
Detailed structural–functional insight on disorder, how-
ever, can only be expected from powerful biophysical meth-
ods. Collectively, they have provided evidence that IDPs are
not featureless (random coil-like) polypeptide chains, they
have diverse, function-related, transient short-and long
range structural organization. The uncontested champion
of IDPs is nuclear magnetic resonance (NMR), which pro-
vides residue-level data on structural preferences and
dynamic features of proteins in the disordered state. The
technique can be complemented by a range of other
approaches, such as small-angle X-ray scattering (SAXS),
circular dichroism (CD), calorimetry (isothermal titration
calorimetry (ITC) and differential scanning calorimetry
(DSC)), fluorescence spectroscopy, X-ray crystallography,
and many more. The combination of distinct biophysical
approaches and advanced computational tools enables to
describe the real ensemble of IDP/IDR structures [Fisher
and Stultz, 2011]. In the case of cytoskeletal proteins, such
ensemble description has been achieved for tau protein
[Mukrasch et al., 2009] (cf. Fig. 3). A descriptive list of
human cytoskeletal proteins (from the DisProt database
[Sickmeier et al., 2007]) for which there is biophysical evi-
dence and characterization of the involvement of disorder,
is provided in Supporting Information Table S2.
In this review, we would like to describe the great variety
of structural/functional associations of structural disorder in
the cytoskeleton. Bioinformatics predictions [Ward et al.,
2004] and scattered experimental observations [Czisch
et al., 1993; Hernandez et al., 1986; Mukrasch et al., 2009]
already provided evidence for the frequent and important
involvement of structural disorder in the organization and
regulation of cytoskeleton. As already suggested, all three
major constituents of the cytoskeleton have similar basic
design: they have a central fibrillar core made of structured
building blocks (coiled-coil head-domain in NFs, G-actin
in microfilaments and tubulin heterodimers in MTs), regu-
lated by a great variety of accessory proteins (side-arms in
the case of neurofilaments), which carry out diverse func-
tions and usually show a high level of structural disorder
(cf. Fig. 1 through 5). Altogether, our search for cytoskeletal
proteins in UniProt resulted in 1457 unique hits for Homo
sapiens (Supporting Information Table S1, see also Table I
for select examples), which overall show a high level of
structural disorder (28%). The number of components
associated with the three cytoskeletal systems in humans
(IFs: 160, MTs: 358, actin filament: 1029) clearly show
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their increasing complexity, perhaps not accidentally also
correlating with their average disorder (IFs: 0.13, MTs:
0.31, actin filament: 0.30). The distribution of structural
disorder shows substantial heterogeneity (Fig. 1A, many
proteins with little disorder, mostly core components and
modifying enzymes, and many with higher disorder, mostly
other regulatory proteins cf. Figs. 1B and 1C). On the aver-
age, cytoskeletal proteins have two long IDRs (Fig. 1C). In
all, more than 40% of cytoskeletal proteins have more than
30% of their residues disordered (cf. Supporting Informa-
tion Table S1).
As outlined in great detail in the following sections,
structural disorder often plays important roles in all three
systems in: post-translational modification (tubulin tails,
NF side-arms, practically all other accessory proteins),
sequestration/stabilization of folded building blocks (actin:
Tbeta4 [Safer et al., 1997], tubulin: stathmin [Wallon
et al., 2000]), promotion of polymerization (MTs:
microtubule-associated proteins (MAPS) [Dehmelt and
Halpain, 2005], microfilaments: Spire and Cordon-Bleu
[Renault et al., 2008]), providing a flexible spacer between
filamentous core (NFs: side-arms [Brown and Hoh, 1997],
MTs: MAPs [Mukhopadhyay and Hoh, 2001]), connecting
to other elements (actin crosslinkers), targeting activity or
signaling cascades (MTs: MAPs as A-kinase anchoring pro-
teins (AKAPs) [Buday and Tompa, 2010]), creating a spe-
cial physical microenvironment (NFs: phase transition of
side-arms [Beck et al., 2012]) and much more complex reg-
ulatory relations. Structurally disordered accessory proteins
are also involved in mediating the crosstalk between the dif-
ferent components of the cytoskeleton (average disorder
0.32, for 87 proteins involved with two or more cytos-
keletal components, cf. also Table I).
Intermediate (Neuro) Filaments and
Disorder
IFs constitute a principal filament system in metazoan cells
[Fuchs and Weber, 1994] and IF proteins represent one of
the most abundant cellular proteins. Within the cytoplasm
and nucleus, they assume various flexible intracellular
Fig. 1.
Fig. 1. Distribution of disorder in the three cytoskeletal
components. Disorder properties of all 1457 proteins involved
in the cytoskeleton. (A) Histogram of predicted disorder
(IUPred) shows a long tail in the distribution, (B) Average dis-
order of all proteins and separately for proteins involved with
each filament type (IFs, MTs, and Actin). In addition, the pro-
teins in each class are divided into two subcategories: enzymes
and others. Enzymes are selected based on the presence of an
EC number in the UniProt annotation. (C) Average number of
long disordered regions (LDRs) for each protein subclass. LDRs
are defined as 30 (or more) consecutive predicted disordered
residues. Intervening stretches of upto three residues are
ignored. In (B) and (C), standard deviations for all the bars are
large, and therefore not plotted, so as to retain focus on the
observed overall trends. In both plots, the number of proteins
associated with the subgroups are: 210 (all_enzymes), 1247
(all_others), 8 (if_enzymes), 152 (if_others), 50 (mt_enzymes),
308 (mt_others), 172 (actin_enzymes), and 857 (actin_others);
if5 intermediate filaments, mt5microtubules.
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scaffolds depending on the cell type (Fig. 2). The IF net-
work protects the cell against mechanical stresses [Lazarides,
1982] and plays role in several basic cellular processes (cell
growth, proliferation and apoptosis) by interacting with
various cellular proteins [Kim and Coulombe, 2007]. They
were designated “intermediate” because their average diam-
eter of 10 nm falls between thinner microfilaments (5–8
nm) and thicker MTs (25 nm). So far, about 70 genes
Fig. 2. Structural organization of IF fibers. Typical pathway of structural organization of intermediate filaments. A dimer of exten-
sive coiled-coil structure forms of two monomers, forming a tetramer via lateral interactions and protofilaments via head-to-tail con-
tacts. Disordered tail domain protrude from mature filaments and provide a platform for further interactions with accessory protein
and post-translational modifications.
Fig. 3. NMR measurement and disorder prediction of tau protein. Major conformational features of human tau protein calculated
from NMR data. The diagram above the domain structure shows the major transient short-range structural motifs observable: tran-
sient a-helical structure H1 and H2 (red cylinders), and b-structures, of which B2, B3, and B4 are highlighted (yellow arrows). Poly-
proline II stretches are shown as green boxes. In the lower panel, an ensemble of 20 conformations, with one highlighted by the
secondary structural elements, is shown. The same conformation is also shown to the right, color coded according to the domain
organization of tau. Adapted from PLoS Biology [Mukrasch et al., 2009] with permission.
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belonging to the IF superfamily in six subfamilies were
identified [Herrmann et al., 2003; Szeverenyi et al., 2008].
The genomic structure and the nucleotide sequence
homology throughout the rod domain define the six major
types (I–VI). The 28 type I and 26 type II intermediate fila-
ment proteins are the “acidic” and “basic” keratins, and
account for most of the intermediate filaments (Table I).
Keratins only assemble as heteropolymers: a type I and a
type II protein form a heterodimer. There are four type III
genes: desmin (muscle cells); vimentin (fibroblasts, lympho-
cytes, endothelial cells); peripherin, (peripheral neurons)
and syncoilin. The seven type IV IF proteins are expressed
mostly in nerve cells where they are implicated in the radial
growth of the axon. The type V nuclear lamin IF proteins
form intranuclear filaments. The type VI group includes
the two eye lens intermediate filament, or “beaded
filament”, proteins CP49 (phakinin), and filensin (CP115).
The encoded proteins can be found in practically all cell
types of the human body, but in neurons they are especially
abundant (NFs). The conserved regions harbour a number
of phenotypically pronounced point mutations in IF genes,
which have been associated with at least 90 different
diseases causing hair and nail defects, epithelial blistering
disorders, heart or skeletal muscle abnormality, cardiomy-
opathies, neuropathies, and metabolic syndromes [Fuchs
and Cleveland, 1998; Omary et al., 2004; Szeverenyi et al.,
2008].
General Outline of IFs
IF components are much more diverse in their sequences
than other cytoskeletal network elements, for example,
MTs. Two well defined conserved regions can be identified
across different IF proteins, both is located in an a-helical
segment of the central rod domain and one is an absolutely
conserved 13 amino acids long IF “consensus” motif,
involved in dimer–dimer interactions within the mature fil-
ament [Herrmann et al., 2000]. Despite their diversity,
members of the IF superfamily share similar patterns of sec-
ondary structure, dominated by a central rod domain and
flanked by head and tail domains [Hertzog et al., 2004].
During IF formation, two parallel a-helical chains scroll
into an extended coiled-coil dimer (Fig. 2). Following the
head-to-tail association of the rods (usually 310 amino acids
long) antiparallel protofibrils are formed. Two dimers join
side-by-side to form a bidirectional, staggered antiparallel
tetramer [Steinert et al., 1993; Strelkov et al., 2002], and
mature IFs are assembled from these apolar tetramers form-
ing so called “unit-length filaments” [Herrmann et al.,
1996] by internal rearrangement of subunits and radial
compaction of the filament [Herrmann and Aebi, 1999].
Although the ideal structural model of intermediate fila-
ment (Fig. 3) supposes eight tetramers in four distinct sub-
fibrils, there is significant structural polymorphism among
intermediate filaments [Goldie et al., 2007; Sokolova et al.,
2006]. IFs are dynamic structures; several cross-linking pro-
teins were identified to mediate interactions between inter-
mediate filaments and the other cytoskeletal networks like
plectin in vimentin fibers [Favre et al., 2011; Karashima
et al., 2012] or filaggrin in keratin [Mack et al., 1993] (cf.
Table I).
IFs are obligate heteropolymers composed of three subu-
nits, IF-L(ight), IF-M(edium), and IF-H(eavy), which dif-
fer in their molecular weight (Mw) (68–70, 145–160, and
200–220 kDa, respectively). The central rod region is
divided into four a-helical segments (1A, 1B, 2A, 2B) sep-
arated by three linker regions (L1, L12, L2) and flanked by
nonhelical N-terminal head and C-terminal tail (CTT)
domains [Fuchs and Weber, 1994]. The variable head and
tail ends of IF proteins play key roles in the assembly, orga-
nization and regulation of intermediate filaments, for
example, via post-translational modifications and interac-
tions with other proteins [Kim et al., 2006]. The terminal
regions that are predicted (Table I) and experimentally
shown [Brown and Hoh, 1997] to be disordered, show
wide variety in their length and sequence and are usually
made up of three distinguishable regions. E1 (head) and
E2 (tail) subdomains are highly charged; V1 (head) and
V2 (tail) are variable domains containing loose repeat
sequence motifs, and H1 (head) and H2 (tail) are
“hypervariable” stretches that often contain phosphoryla-
tion target sites [Szeverenyi et al., 2008]. For example, the
tail domain of IF-H contains more than 100 copies of a
hexapeptide element, which harbours a characteristic KSP
phosphorylation motif that contributes multiple sites for
phosphorylation determining interfilament spacing [Brown
and Hoh, 1997]. Phosphorylation of the head region can
affect filament stability and it can also be involved in exten-
sive cross-linking activities giving rise to hydrogel transi-
tions [Beck al., 2012].
Neurofilaments are Special
Among IFs, NFs have unique properties. Three markedly
different proteins called triplet proteins (NF-L, NF-M, and
NF-H) constitute two morphologically distinct domains:
core filaments and cross-bridges [Lee and Cleveland, 1996],
the latter being only 3–5 nm in diameter. The NF triplet
proteins are present in both the central and peripheral nerv-
ous system and are usually neuron specific. The carboxy-
terminal domains of NF-M (60 kDa) and NF-H (200
kDa) extend from the filament backbone and project away
from the filament as side-arms [Leapman et al., 1997],
forming cross-bridges through noncovalent interfilament
interactions [Chen et al., 2000; Nakagawa et al., 1995].
NFs fill the core of the axon with a characteristic interfila-
ment spacing of 35–40 nm, which depends on the phos-
phorylation state and entropic exclusion of the tail domain
[Brown and Hoh, 1997; Kumar and Hoh, 2004; Martin
et al., 1999; Strong et al., 2001].
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The tail domain of NF-H is longer and contains a multi-
phosphorylation repeat domain with much more Lys-Ser-
Pro (KSP) motifs, than NF-M [Pant et al., 2000], the ser-
ines of which are targets for phosphorylation. The level of
phosphorylation varies within the cell; in distal regions of
axons are the side-arms the most heavily phosphorylated
and they are largely nonphosphorylated in perikarya and
more distal regions of axons [Nixon et al., 1994]. The tails
attain additional negative charges through serine phospho-
rylation which mediates the interaction between neighbor-
ing filaments, affects the organization of NF brushes and is
considered to increase the lateral extension of sidearms
[Martin et al., 1999]. Phosphorylation of NF-H side arms
also regulates transport of NFs through axons [Ackerley
et al., 2003; Lee et al., 2012].
Structural Studies
Due to their polymerization-prone character, IFs or IF pro-
teins have not yet been crystallized. Rather, discrete
domains or fragments are selected for crystallization and
such structural data are now available for various fragments
of vimentin, lamin A, and keratin, and also for the nonheli-
cal tail domain of lamin A/C and vimentin.
The first pieces of structural information were obtained
for vimentin, one of the best conserved IF proteins.
Recently a human vimentin mutation has been linked to
cataracts [Muller et al., 2009]. The molecular organization
of human vimentin based on the crystal structures of three
fragments [Strelkov et al., 2002] suggests that the fragment
corresponding to segment 1A forms a single amphipatic a-
helix, which might yield a coiled coil within an isolated
dimer and is likely to play a role in specific dimer–dimer
interactions during IF assembly. The 2B segment reveals a
double-stranded coiled coil, which interferes heavily with
IF assembly. The model could be later extended to the first
half of its rod domain [Chernyatina et al., 2012] leading to
an antiparallel tetramer model (cf. Fig. 2).
Nuclear lamins (also known as class V IFs) are special
nuclear IFs, which form a two-dimensional matrix provid-
ing integrity and structural support for chromosomes and
replicating DNA. Together with chromatin proteins and
inner nuclear membrane proteins, they form the nuclear
lamina which is essential for maintaining proper nuclear
shape, spacing nuclear pore complexes and organizing het-
erochromatin [Stuurman et al., 1998]. The intertwining of
lamin filaments and their carboxyl-terminal segments dis-
tinguish them from other IFs. Multiple alignments of the
available amino acid sequences of lamins revealed two
regions of high homology connected by a variable-length
disordered linker [Krimm et al., 2002]. The first homology
domain corresponds to the coiled coil rod domain common
to all IF proteins, whereas the second C-terminal domain is
unique to lamins and appears to be globular by electron
microscopy [Stuurman et al., 1998].
Assembly of IFs
The role of head and tail domains in IF assembly has been
studied by mutagenesis and in vitro assembly studies [Hatz-
feld and Burba, 1994; Herrmann et al., 1996; Kouklis
et al., 1993]. It is generally agreed that the head domain is
more important in IF assembly than the tail domain; its
deletion interrupts filament assembly at the dimer/tetramer
stage [Beuttenmuller et al., 1994; Herrmann et al., 1996].
The tail domain containing the conserved TRDG motif is
at least partially responsible for proper filament thickness
[Makarova et al., 1994]. A study of the interaction between
the isolated vimentin tail domain and actin containing
structures suggested that the vimentin tail existed mainly in
an extended conformation [Cary et al., 1994].
Although the role of structural disorder in IF function is
recognized for some time [Ackerley al., 2003; Brown and
Hoh, 1997], relatively little attention has been paid to the
structural description of the flexible tail or head domain of
IFs. Using site directed spin labeling and electron paramag-
netic resonance (EPR), the structure and dynamics of the
head domain of human vimentin [Aziz et al., 2010] and its
tail domain in tetramers and filaments was studied and
compared recently [Hess et al., 2013]. As opposed to head
and rod domains, the tail domains are not closely apposed
in protofilaments. More than half of the tail domain is very
flexible in both the assembly intermediate and the intact IF:
its first third, being a continuation of the central rod
domain, is rather rigid and ordered, to transit abruptly to a
more flexible, less ordered region (cf. Fig. 2) as shown by
EPR. The tail domain is involved in protein/protein inter-
actions that occur during filament elongation.
Involvement in Disease
97 distinct diseases have been associated with the IF gene
family: inherited mutations affecting the primary structure
of IF proteins are responsible for a vast number of inherited
diseases and result in the formation of characteristic cyto-
plasmic inclusions [Fuchs and Cleveland, 1998; Wilson
et al., 2001]. The majority of these genetic lesions are mis-
sense mutations affecting highly conserved residues at either
the N- or the C-terminus of the central rod domain. Several
hair, nail and skin defects were linked to mutations in the
gene of type I or II keratins including epidermolysis bullosa
and keratoderma disorders [Irvine and McLean, 1999].
Desminopathy is one of the most common intermediate fil-
ament human disorders associated with mutations in closely
interacting proteins, desmin and alpha B-crystallin [Clemen
et al., 2009]. In contrast to previous findings, where the dis-
order causing mutations were located mainly to the central
region of IF proteins, in desmin tail domain mutations
were as well described [Maddison et al., 2012]. Desmin is
involved in several types of cardiomyopathy, too. The
Charcot-Marie-Tooth disease and Parkinson’s disease are
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progressive neurological degenerations associated with
mutations in NF genes. Laminopathies, the most pheno-
typically diverse group of IF gene related pathologies, are
the collective term for diseases caused by mutations in the
lamin genes [Wilson et al., 2001]. The role of vimentin
and type VI IF proteins in autosomal dominant cataract has
been published recently [Muller et al., 2009]; mutations in
the gene encoding the carboxyl-terminal tail of Lamin A/C
are associated with forms of muscular dystrophy and fami-
lial partial lipodystrophy [Wilson et al., 2001].
Microtubules
MTs are the largest of the filamentous cytoskeletal struc-
tures that pervade the cellular cytoplasm and help in the
maintenance of cell shape, motility, divisions and intracellu-
lar transport. They are rigid, tubular filaments with a diam-
eter of about 25 nm, built as a polymer of heterodimeric a/
b tubulin subunits [Amos, 2000]. In cross-section, each
MT is shown to consist of 13 individual (proto-) filaments
assembled around a hollow core. Each protofilament is
composed of a series of tubulin molecules that are linearly
arranged with the same polarity (i.e., with identical head-
to-tail orientation of the a/b-subunits), resulting in a plus
(fast-growing) and a minus (slow-growing) end [Nogales,
2001]. MTs usually grow from specific nucleating sites in
the cell (MT organizing centers), most commonly the cen-
trosome, and nucleation involves a g-tubulin variant [Koll-
man et al., 2011]. The minus ends of MTs are stabilized
because they are embedded in the centrosome, whereas
their plus ends grow outwards towards the cell boundaries.
MTs undergo rapid cycles of polymerization and depoly-
merization (dynamic instability): this behaviour is regulated
by GTP binding and hydrolysis [Howard and Hyman,
2009; Wade, 2009]. This inherent (dynamic) instability of
MTs is carefully regulated by the cell (regulatory mecha-
nisms include posttranslational modifications of the tubulin
dimer, and the binding of MAPs) for specific functional
purposes [Etienne-Manneville, 2010; van der Vaart et al.,
2009].
Structural Aspects of the “Core”
Microtubular Proteins
The MT core is composed of heterodimers of a- and
b-tubulin, which have an N-terminal domain containing
the nucleotide-binding region, an intermediate domain
containing the taxol-binding site, and a C-terminal domain
(PDBid: 1TUB) that ends in a highly acidic, disordered tail
[Nogales et al., 1998], also observable in b-tubulin. NMR
experiments [Lefevre et al., 2011], computational modeling
[Freedman et al., 2011] and missing electron density for
the CTT in crystal structures provide clear evidence for its
highly flexible/disordered nature. The tubulin CTT pro-
trudes from the MT surface and functions as the site of
most of the post-translational modifications of tubulin
[Sahab et al., 2012]. The CTT is also functionally impor-
tant as it forms the binding site for a variety of tubulin/MT
partners, including molecular motors [Wang and Sheetz,
2000], diverse MAPs (such as MAP2, tau and MAP4), and
cations (such as Ca21) which are all major regulators of
MT (dis)assembly and dynamics [Garnham and Roll-
Mecak, 2012; Janke and Bulinski, 2011]. The variations of
CTT among tubulin isotypes potentially explain the modu-
lation of the dynamics of MT assembly in specific tissues or
cytoplasmic regions.
The exterior of the MT shaft consists of the highly disor-
dered, negatively charged tubulin tail. Post-translational
modifications of the tubulin CTT create specialized MT
surfaces that are geared towards manifold functions. Recent
research has highlighted the large variety of tubulin modifi-
cations including Lys acetylation, arginylation, glutamyla-
tion, glycosylation, methylation, etc. [Wloga and Gaertig,
2010]. The observation that modified tubulin subunits are
unevenly distributed along MTs has led to the hypothesis
that the diverse post-translational modifications (PTMs)
form a biochemical “tubulin code” that can be interpreted
as a signal by MT interacting proteins/factors [Verhey and
Gaertig, 2007]. The MT array can thereby be considered to
comprise a block co-polymeric architecture composed of
tubulin heterodimers, and with the PTMs of the tubulin
building blocks marking MT subpopulations, thus selec-
tively affecting downstream MT-based functions [Janke and
Bulinski, 2011]. To add to the complexity, in PTMs such
as poly-glutamylation and poly-glycylation, the specific
length of the added chain can vary (glutamic acid chains
are usually between 1 and 6; however, up to 20 have been
observed). At neutral pH, the CTT negative charges cause
it to remain extended due to the electrostatic repulsion
within the tail, and between adjacent tails. These PTMs
would not only differentially increase the chain length, but
also alter the charge distribution and balance, all serving to
fulfill (not all of which are understood at present) definite
regulatory roles [Garnham and Roll-Mecak, 2012]. From
the evolutionary standpoint, it seems logical that such regu-
latory functionalities were primarily added to the peripheral
(exposed) tubulin tail, and not the tubulin body that is
involved in “core” lattice interactions and where modifica-
tions would be likely to result in loss of viability. In accord-
ance with what is known about the advantages of protein
disorder, it is not surprising that this regulatory CTT seg-
ment is also highly unstructured.
Interestingly, the bacterial tubulin homolog FtsZ also has
a marked disordered CTT (40–50 residues). FtsZ is present
ubiquitously in eubacteria, archaebacteria and has also been
identified in chloroplasts [Erickson, 1997]. As with tubulin,
FtsZ also serves a cytoskeletal role as demonstrated by its
formation of protofilament sheets and mini-rings that serve
as the cytoskeletal framework for a contractile ring structure
(Z ring) at the future cell division site [Erickson et al.,
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2010]. The timing and the location of cell division is regu-
lated by ring assembly. The FtsZ ring further recruits other
cell division proteins to the septum to produce a new cell
wall between the daughter cells. Homodimerization of FtsZ
requires the central region and the disordered CTT, which
is the first step towards polymerization and formation of
the dynamic Z ring. Critical to cell division, the Z ring for-
mation is under tight regulation, and FtsZ has multiple
binding partners. It is increasingly evident that a conserved
stretch of amino acids at the CTT of FtsZ is involved in
many of these interactions; evidence has been reported for
the interaction of the CTT with MinC, FtsA, EzrA, ClpX,
and SepF. Mutations in the C-terminal conserved core have
been described that abolish binding to one or more partners
[Krol et al., 2012]. Although disordered in the unbound
form, recent crystal and NMR structures demonstrate the
functional role of disorder in the binding via disorder to
order transitions. Bound to ZipA, the C-terminal peptide
forms an extended b-strand followed by an a-helix, whereas
bound to FtsA the peptide is predominantly helical (thereby
demonstrating that the FtsZ CTT can adopt different con-
formations to fit different binding partners).
Microtubule-Associated Proteins
(MAPs)
Research over several decades has resulted in an expanding
list of MAPs, knowledge of their phosphorylation states,
and their effects on MT dynamics and regulation [Mandel-
kow and Mandelkow, 1995]. Several types of MAPs have
evolved in eukaryotes, including structural MAPs, microtu-
bule plus-end-binding proteins (1TIPs) and MT motors
(cf. Table I).
“Structural” MAPs
“Structural” (or assembly-) MAPs bind to, stabilize and
promote MT assembly. These proteins share a conserved C-
terminal domain containing MT-binding repeats, and a
variable projection domain (that serves to scaffold MTs
with other cellular proteins, intermediate filaments, mem-
brane components and neighboring MTs). In electron
micrographs, the projection domain appears as a filamen-
tous arm extending from the MTwall.
Based on sequence features, MAPs have two main fami-
lies: Type I (MAP1A/1B) and Type II (MAP2, Tau, and
MAP4), and several isoforms generated by alternative splic-
ing. MAP1A/1B are large, filamentous proteins found in
axons and dendrites of neurons and also in non-neuronal
cells [Halpain and Dehmelt, 2006]. Structural details of
MAP1-family proteins are largely unknown. Electron
microscopy studies have however suggested their elongated,
flexible shape [Sato-Yoshitake et al., 1989; Shiomura and
Hirokawa, 1987] and disorder predictions indicate that
both MAP1A and 1B are extensively disordered (Table I).
They contain basic KKEX (Lys-Lys-Glu-X) repeats that
bind to negatively charged tubulin [Noble et al., 1989] and
potentially reduces charge repulsion between tubulin subu-
nits within MTs, thus stabilizing the polymer.
Type II MAPs include MAP2 and Tau (found in neu-
rons), and the ubiquitous MAP4 (present in neuronal and
many non-neuronal tissues) [Dehmelt and Halpain, 2005].
In mature neurons Tau is present mainly in axons whereas
MAP2 is restricted to cell bodies and dendrites. MAP2 and
Tau can form fibrous connections (cross-bridges) between
MTs and form stable MT bundles. MAP4 is thought to
regulate MT stability during mitosis. Type II MAPs possess
three or four repeats of an 18-residue stretch in the MT-
binding domain [Al-Bassam et al., 2002]. Reversible phos-
phorylation of MAPs promotes MT disassembly because
phosphorylated MAPs are unable to bind to MTs, a struc-
ture occurs with Tau in Alzheimer’s disease, for example
[Gong and Iqbal, 2008].
MAP2 and Tau (Fig. 3) proteins are intrinsically disor-
dered [Mukrasch et al., 2009]. All MAP2/Tau family pro-
teins have MT-binding repeats near the C-terminus
[Goedert et al., 1991], each containing a conserved KXGS
motif that can be reversibly phosphorylated. These repeats
constitute the “core” MT-binding region that undergoes
disorder-to-order transition during MT binding. The N-
terminal projection domain has a net negative charge and
exerts a long-range repulsive force [Mukhopadhyay and
Hoh, 2001], thus behaving as “entropic chains” to regulate
inter-MT spacing in axons and dendrites [Chen et al.,
1992]. Functional orthologs of MAP2/Tau proteins are
found in diverse organisms such as C. elegans (PTL-1) and
D. melanogaster that are also predicted 100% disordered.
The nature and behavior of protein disorder in case of
Tau has been extensively characterized by several bio-
physical techniques (Supporting Information Table S2)
[Narayanan et al., 2010]. NMR secondary chemical
shifts and dipolar couplings detect b-structure propen-
sity within the MT-binding four-repeat region and
largely random coil structure in the flanking domains.
Chemical shift perturbation experiments also identify
motifs in both the upstream and downstream flanking
domains, (225)KVAVVRT(231) and (243)LQTA(246)
respectively, that strongly contribute to the binding to
the acidic MT exterior. This model is consistent with
the "jaws" model of Tau-MT interactions and clearly
highlights the importance of the disordered regions for
both MT binding and pathological Tau aggregation
[Mukrasch et al., 2007].
In addition to MT binding and stabilization, these MAPs
also modulate cargo transport and regulate MT dynamics
by performing adaptor functions by anchoring signaling
proteins in an adaptive binding process [Gundersen and
Cook, 1999]. Binding of MAP2 to the RII regulatory subu-
nit of PKA is a very well-characterized example of a classical
MAP functioning as an adaptor protein [Obar et al., 1989]
CYTOSKELETON Intrinsic Structural Disorder 559 
due to which they belong to the family of A-kinase anchor-
ing proteins (AKAPs).
MT Plus-End Tracking Proteins
(1TIPs)
1TIPs constitute a structurally and functionally diverse
protein family whose members specifically bind to and
accumulate at the plus ends of MTs [Akhmanova and Stein-
metz, 2010], which is highly dynamic and undergoes alter-
nating phases of growth and shrinkage (catastrophe). A
variety of intracellular processes critically depend on MT
dynamics in which 1TIPs play important roles. 1TIPs
exhibit a limited set of evolutionarily conserved linear
motifs, which feature in domain-linear motif-mediated
interactions that interface the MT system with other cellular
structures and signaling networks [Akhmanova and Stein-
metz, 2008]. These recognition regions typically appear
within regions of predicted disorder which are involved in
specific but reversible (with low micromolar affinities) bind-
ing typical of IDPs. 1TIPs have four major classes (cf.
Table I).
(1) End-binding (EB) family: the members contain a
strongly conserved N-terminal calponin homology
(CH) domain [Hayashi and Ikura, 2003] and an
adjacent linker region which cooperate in binding
MT plus ends. The C-terminal region consists of an
a-helical coiled-coil domain, an EB-homology
domain and an acidic tail bearing an EEY/F linear
motif. The EBH domain and the acidic EEY/F motif
act as interaction hubs and enable EB proteins to
interact with a gamut of other 1TIPs and recruit
them to MT ends, typical of the moonlighting
capacity of IDPs/IDRs [Tompa et al., 2005].
(2) Cytoskeleton-associated protein glycine-rich (CAP-
Gly) domain: this is a small globular domain con-
taining an evolutionary conserved hydrophobic cavity
and multiple Gly residues at specific locations. CAP-
Gly domains use their apolar cavity to interact with
MTs and the consensus EEY/F sequence motifs of
EB family proteins. The best-studied members of this
family are CLIP-170 and the dynactin complex
p150glued. Disorder predictions for p150glued show
that the CAP-Gly domains (regions 78–120, 232–
274) are ordered, but there are other long disordered
regions in the protein (cf. Table I).
(3) SxIP motif-containing 1TIPs: These are characterized
by low-complexity sequence regions enriched in basic,
serine and proline residues that form the SxIP-motif.
This motif acts as a general “microtubule tip localiza-
tion signal” (MtLS) that is specifically recognized by
the EBH domain of EB-family proteins and thereby
causes these proteins to be recruited to the MT-plus
ends. Well-characterized members include the
adenomatous polyposis coli (APC) tumor suppressor,
the spectraplakin microtubule-actin crosslinking factor
(MACF1) and the mitotic centromere-associated
kinetin (MCAK). Disorder predictions of all these pro-
teins show several long disordered regions (cf. Table I).
(4) TOG/TOG-like domain containing proteins: this class
includes members of the XMAP215 and CLASP fami-
lies that play central roles in the regulation of inter-
phase MT dynamics and the proper formation of
mitotic spindle architecture and flux. Their character-
istic feature is the presence of tandem arrangement of
TOG domains that enable binding to tubulin [Slep,
2009]. CLASPs additionally contain SxIP-motifs that
enable plus-end binding and stabilization.
MT Destabilizers
The Op18/stathmin family are well characterized IDPs that
destabilize MTs and increase their turnover, thus making
possible rapid reorganization of the microtubular cytoskele-
ton [Cassimeris, 2002]. This destabilization occurs either
by stathmin causing the sequestration of tubulin dimers, or
by the stimulation of MT plus-end catastrophes. In solu-
tion, free Op18/stathmin has negligible secondary struc-
ture, existing in a rapid equilibrium between a disordered
ensemble and a state more structured containing a long a-
helical structure [Steinmetz et al., 2000]. Binding to tubu-
lin stimulates folding of a large region of Op18/stathmin
into a long, extended a-helix, with the terminal region
inhibiting elongation of the polymer (Supporting Informa-
tion Table S2).
Microtubular Motor Proteins
Another broad class of MAPs are motor proteins that use
MT as “railway tracks” in intracellular transport [Mallik
and Gross, 2004]. Two large superfamilies have been identi-
fied: kinesins transport cargo towards plus ends of MTs,
whereas dyneins drive minus end-directed retrograde trans-
port. Both motors consist of two heavy chains and several
light chains. Each heavy chain is composed of a conserved,
globular ATPase head domain, and an elongated tail region.
Kinesin is the founding member of the diverse kinesin
superfamily [Hirokawa et al., 2009]. It contains two identi-
cal approximately 960-residue heavy chains containing an
N-terminal globular motor domain, a central a-helical stalk
that enables dimer formation through a coiled-coil, and a
CTT (Fig. 4A) that is both autoregulatory (binds to the
motor domain to inhibit its ATPase activity), and also
responsible for specific cargo selection [Karcher et al.,
2002]. The adaptor domains are structurally diverse thus
enabling specific cargo selection. Intrinsic disorder is a com-
mon structural feature of nonmotor domains of kinesins
(cf. Table I) [Seeger et al., 2012], confirmed by CD and
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NMR structural studies [Seeger et al., 2012]. The disor-
dered nature of these tail regions plays an important role in
facilitating cargo recognition and conferring functional
specificity to kinesins (cf. Table I).
Several insights can be obtained by comparing available
structural data for molecular motors with disorder predic-
tions. In kinesin, for example, 20% of the motor domain
is predicted as disordered (Fig. 4B), within loops 1, 2, 7,
10, and 12, the P-loop, Switch I and II, and the neck-
linker. Several of these structures undergo conformational
changes in response to events such as nucleotide exchange
and/or MT-binding and release [Kull and Endow, 2002;
Sindelar and Downing, 2010]. Cryo-electron microscopy
(EM), electron paramagnetic resonance spectroscopy
(EPR), Forster resonance energy transfer (FRET), etc.
studies indicate a large-scale conformational change in the
disordered neck-linker region following ATP and MT-
binding, thus demonstrating the role of structural disorder
in the communication link between the ATP and MT-
binding sites and the neck linker [Vale et al., 2000].
The mechanism of powered motion requires an impor-
tant disorder-to-order transition as elegantly demonstrated
by two kinesin structures (PDBid 1bg2: before; and, 2kin:
after the power stroke), which show how a small change
due to ATP-ADP transition results in a large structural
change in the motor. A small change in the ATP-binding
region upon ATP hydrolysis pushes on the relay helix caus-
ing it to form a perfectly sized pocket for the neck linker.
Before the power stroke, the pocket is too small and the
linker is disordered; after the power stroke, the pocket
attains the correct size for the neck linker to zipper into the
protein (Fig. 4C), dragging along the neck and any attached
cargo.
The structures of kinesin stalks are more complex than
an uninterrupted coiled-coil. In case of the kinesin motor
Kif5B, for example, the stalk contains several short flexible
hinge regions that are predicted to be disordered and enable
the molecule to fold into a compact conformation under
Fig. 4.
Fig. 4. Examples of structural disorder in kinesin motor
structures. (A) Domain organization and predicted disorder of
kinesin (UniProtID: Q6QLM7): values on the y-axis represent
predicted disorder (RONN [Yang et al., 2005]). The value of
0.5 represents the cutoff and residues with values higher than
0.5 are predicted disordered, (B) Cartoon representation of the
kinesin structure (PDBid: 3KIN) consisting of the head domain
and neck linker region. Segments colored red are predicted dis-
ordered (according to values plotted in Fig. 4A), and they are
labeled according to the structural nomenclature used by Koziel-
ski et al. [Kozielski et al., 1997]. The ADP molecule is drawn
in orange spacefill. (C) Disorder-to-order transition in the neck
linker of kinesin during the power stroke. Surface representation
shows the kinesin structure (PDBid: 2KIN) in cyan, with the
‘relay’ helix, the neck linker and the neck start region drawn as
cartoon (red color). Superposed on it is another structure of
kinesin (PDBid: 1BG2), for which only the relay helix and the
CTT at the start of the neck linker sequence are shown in blue
(the neck linker itself is disordered, shown with dotted lines,
and is missing from the crystal structure). The rest of the struc-
ture has been omitted for clarity. Overall the two structures
superpose with a Ca RMSD of 1.97 A˚, and the largest devia-
tions are seen in the relay helix structure. The ATP binding site
is on the opposite face of the molecule and cannot be seen in
this view. ATP hydrolysis causes a subtle conformational change
in the structural elements forming the ATPase active site, that is
transmitted via the relay helix and results in restructuring the
neck linker binding cleft such that the neck linker undergoes a
disorder (blue dots) to order (red cartoon) transition.
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certain conditions [Stock et al., 1999]. Similarly, the stalk
of Kif10 is over 2000 residues long, and predicted to be
mainly coiled-coil with multiple, distinct 10–100 residue-
long regions of predicted disorder. Kinesin-11 proteins are
predicted to have a nearly 100% disordered stalk encom-
passing 1000 residues [Seeger et al., 2012]. Several kine-
sins form coiled-coil heterodimers using their stalk regions,
and the critical feature that evidently enables dimer forma-
tion is the interaction of patches of intrinsically disordered,
oppositely charged residues in the associating monomer
stalks [Chana et al., 2005].
The tail domains of several kinesins are also significantly
disordered (varying in length from tens to hundreds of resi-
dues) and represent the most variable regions of the motors.
These regions might be involved in motor domain autore-
gulation, posttranslational modifications [Guillaud et al.,
2008], and interaction with specific cargoes [Hirokawa
et al., 2009]. The C-terminal disordered tail of the Kif5B
kinesin motor can bind more than 15 unique partners
(including cargo proteins such as Syntabulin, RanBP2,
SNAP 25/23, p180).
Cytoplasmic dynein is another important MT-based
motor that is composed of multiple heavy, intermediate
and light chains. The intermediate chains (IC) have critical
roles in dynein assembly, regulation and cargo binding. The
N-terminal region of ICs bind to diverse light chains and
cellular cargo; this region is intrinsically disordered, and
undergoes induced folding upon binding to the light chains
LC8 and Tctex-1 [Benison et al., 2006] (Supporting Infor-
mation Table S2). Multipartner binding interactions is also
the primary function of dynein light chain protein LC8.
This protein can bind over 22 different proteins, and these
distinct interactions are all accommodated while maintain-
ing binding specificity through specific interactions between
disordered residues on both the LC8 and its ligands
[Nyarko et al., 2011].
Involvement in Disease
The MT system—or its components—are involved in dis-
tinct diseases. Tau is implicated in Alzheimer disease where
the neuronal cytoskeleton in the brain is progressively dis-
rupted and replaced by tangles of paired helical filaments
(PHF) mainly composed of hyperphosphorylated Tau
[Zheng-Fischhofer et al., 1998]. Defective Tau also causes
frontotemporal dementia, characterized by presenile
dementia with behavioral changes, deterioration of cogni-
tive capacities and loss of memory. The MT system is also
involved in cancer, because disrupting MT dynamics affects
mainly rapidly dividing cells, which is why small molecules
such as Paclitaxel, Taxotere etc. are potent agents for chem-
otherapy [Jordan and Wilson, 2004]. Defects in cytoplas-
mic dynein can cause Charcot-Marie-Tooth disease
[Weedon et al., 2011], characterized by progressive muscle
weakness and atrophy. It can also cause mental retardation
autosomal dominant type 13, characterized by below aver-
age intellectual functioning and behavioral impairments.
APC protein is involved in familial adenomatous polyposis,
contributing to tumor development and characterized by
adenomatous polyps of the colon [Rustgi, 2007] and rec-
tum, but also of upper gastrointestinal tract. APC disregula-
tions also the cause of gastric cancer, mismatch repair
cancer syndrome, and medulloblastoma. Defects in dynac-
tin are the cause of progressive lower motor neuron disease:
a neuromuscular disorder and Parkinsonism with alveolar
hypoventilation and mental depression (Perry syndrome),
and also susceptibility to amyotrophic lateral sclerosis
[Rustgi, 2007].
Actin Cytoskeleton
In eukaryotic cells, actin is the most complex, flexible and
versatile cytoskeletal component responsible for motility,
endocytosis, intracellular trafficking, and cell morphology
(Fig. 5). Actin filaments and monomers interact with an
abundance of actin-binding proteins (ABPs) that organize
actin networks in the cell, connect the actin structures to
other parts of the cytoskeleton, and function in intercellular
signaling [dos Remedios et al., 2003]. Actin is highly abun-
dant in eukaryotic cells and extremely well conserved
among species. Vertebrates usually have six different iso-
forms of actin: a-cardiac muscle actin, a-skeletal muscle
actin, a-smooth muscle actin, b-cytoplasmic actin, g-
cytoplasmic actin, andg-smooth muscle actin, which differ
only slightly in their amino acid sequences [Vandekerck-
hove and Weber, 1978], and their expression pattern varies
between tissue types and developmental stages [Tondeleir
et al., 2009].
Actin exists in cells in two forms: the monomeric globu-
lar G-actin and the filamentous F-actin in the shape of a
two-stranded helix [Oda et al., 2009]. Frequently they form
flexible structures such as filopodia or lamellipodia (Fig. 5)
that help exploring the environment or produce movement
in the absence of motor proteins [Mattila and Lappalainen,
2008]. More rigid actin filaments are for instance stereoci-
lia, found at the surface of hair cells in the inner ear and
serve as detectors for sound [Tilney et al., 1983]. Inside
cells, actin is generally located in the cytoplasm and, to
some extent, also in the nucleus. The major contractile
structures in many nonmuscle cells are stress fibers, bundles
formed from cross-linked actin filaments together with
myosin II, which function in mechanotransduction as
focal-adhesion-anchors.
Actin polymerization is a tightly regulated [Gieni and
Hendzel, 2009] dynamic process where ATP-actin is incor-
porated at the barbed end of the filament while ADP-actin
dissociates from the pointed end [Pollard, 1984]. Each sub-
unit is an enzyme that catalyzes the hydrolysis of ATP to
ADP accompanied by a conformational change, allowing
ABPs to distinguish between the ATP and the ADP forms
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[Graceffa and Dominguez, 2003]. Treadmilling, that is,
polymerization driven by ATPase activity, allows for
dynamic behavior of the structural system and thus for cell
motility at the cost of ATP energy [Oda et al., 2009;
Wegner, 1976]. Nucleation and growth of new filaments is
the limiting step in F-actin formation as it is energetically
unfavorable until three monomers or more associate
[Winder and Ayscough, 2005]. New filaments can also
branch out or severe from an existing filament, which ena-
bles subtle control of filament formation in cell movement,
morphology and muscle contraction [Winder and
Ayscough, 2005].
Nucleation can be initiated via three different mechanisms
that are catalyzed by three main classes of proteins: the Arp2/
3 complex together with nucleation promoting factors
(NPFs), formin family proteins, and tandem W domain-
based filament nucleators [Dominguez, 2010; Firat-Karalar
and Welch, 2011]. All of them initiate filament growth by
forming a stable actin trimer as nucleus and, more interest-
ingly, all three mechanisms utilize proteins with IDRs (cf.
Table I) [Goley and Welch, 2006; Sitar et al., 2011; Xu
et al., 2004].
The Arp2/3 Complex Nucleates
Actin Filaments with the Help of
ABPs
The Arp2/3 complex generates y-branched actin networks by
mimicking the critical trimeric nucleus and subsequently sta-
bilizing filament growth by serving as a pointed-end–capping
protein (CP) [Goley and Welch, 2006]. Y-branched actin
networks are found in lamellipodia and thus involved in cell
movement. During the nucleation, the binding of an actin
monomer, mother filament and an activator NPF stabilize
flexible Arp2 subdomains and hydrolysis of ATP can take
Fig. 5. Structural disorder in actin regulatory proteins. Animal cell with nucleus (orange, left bottom), endoplasmic reticulum
(brown, above the nucleus), vesicles, mitochondria and components of the cytoskeleton: MTs (red), intermediate filaments (green),
and actin filaments (thin black lines) close to the cytoplasmic membrane. Red dots on the actin filaments indicate Arp2/3 complexes
involved in branching. ABPs are involved in regulating all aspects of the function of actin cytoskeleton: they are indicated close to
the sites of processes they are involved in. The ABPs are color coded according to the degree of disorder: no disorder, less than 20%
disordered residues (blue), between 20 and 50% disordered residues (pink), and more than 50% disorder (red).
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place [Nolen et al., 2004]. In vivo, several NPFs such as
WASP can recruit Arp2/3 and actin for de novo nucleation.
The WASP-Homology 2 (WH2 or W) domain, a small, dis-
ordered actin-binding motif is present in all NPFs and tan-
dem W domain-based filament nucleators [Beck et al., 2012;
Dominguez, 2010]. The molecular recognition effector role
of disordered segments in WASP that function via a disorder
to order transition has been demonstrated by crystallography
[Kim et al., 2000] (Supporting Information Table S2). In
NPFs one or more W domains are coupled with C (central
or connecting) and A (acidic) motifs that bind subunits of
the Arp2/3 complex and stabilize it in its activated conforma-
tion. A SAXS study of an activated complex consisting of the
Arp2/3 complex, the verprolin homology domain or WASP2
homology 2 domain, cofilin homology domain, and acidic
region (WCA) of N-WASP and one actin monomer shows a
model of activation clearly depending on the inherent flexi-
bility of the WCA motif to connect Arp2/3 with G-actin
[Boczkowska et al., 2008]. Other WCA carrying members of
this group (also called class I NPFs), are WASH, WHAMM,
SCAR/WAVE, and JMY [Dominguez, 2010; Rottner et al.,
2010] (cf. Table I). The class I factor JMY (junction-media-
ting and regulatory protein) is frequently described as one of
the tandem W domain-based filament nucleators due to its
ability to nucleate actin filaments in the presence and absence
of Arp2/3 [Rottner et al., 2010] by “monomer-clustering”
similar to Spire and Cordon-bleu, where several actin mono-
mers are arrayed along a stretch of WH2 repeats [Sitar et al.,
2011; Zuchero et al., 2009]. Actin itself can also be present
in the nucleus where it might be involved in transcription
regulation [Philimonenko et al., 2004].
Class II NPFs, however, contain the acidic Arp2/3 bind-
ing domain but possess an F-actin binding region. In the
case of cortactin (Table I), binding to F-actin occurs
through the central cortactin repeats, a molten globule
domain that presumably undergoes ligand induced folding
[Shvetsov et al., 2009]. The actin binding domain consists
of four to six repeats made up of 37 amino acids connected
to a SH3 domain by a disordered proline-rich region con-
taining regulatory phosphorylation sites [Weed et al.,
2000]. The SH3 domain facilitates binding to other ABPs
containing a conserved prolin-rich motif such as N-WASP
[Mizutani et al., 2002]. When activated, cortactin recruits
Arp2/3 complex proteins to existing actin microfilaments.
Other members of the class II NPFs include Abp1 and
Pan1 that bind F-actin through the structured actin-
depolymerizing-factor homology or a coiled coil domain,
respectively [Goley and Welch, 2006].
Tandem W Domain-Based Assisted
Filament Nucleation
A second class of nucleating proteins that utilize the WH2
motif is the tandem W domain-based filament nucleators
like Spire, Cordon-bleu (Cobl) and leiomodin [Dominguez,
2010; Goley and Welch, 2006; Sitar et al., 2011], which pro-
mote the growth of nonbundled, unbranched actin filaments.
The common nucleation mechanism of these proteins is via
the formation of a filament-like polymerization nucleus
[Dominguez, 2010]. The N-terminal domain of Spire, for
example, binds four actin monomers like beads on a string
with its W domains until they form a polymerization nucleus
of the shape of one strand of the long-pitch helix of the actin
filament [Sitar et al., 2011]. The disordered linkers between
the W domains are rather short in Spire (10 amino acids)
while the brain-enriched Cobl has a 65 amino acid long
proline-rich linker between two of its three W domains giv-
ing Cobl a stronger nucleation activity [Ahuja et al., 2007].
Cobl forms and stabilizes, therefore, an actin trimer with the
third monomer in cross-filament orientation.
Formins Nucleate Unbranched
Filaments
Formins, the third type of nucleators, are generally impli-
cated in the assembly of unbranched filaments, cytokinetic
contractile rings, filopodia, and adherens junctions. They
are large, multidomain proteins with significant sequence
variability. The best studied members, mDia, Bni1, Bnr1,
and DAAM have similar domain architecture and contain a
intrinsically disordered GTPase-binding domain that
adopts helical conformation upon interaction with the
GTPase [Dominguez, 2010]. Formins surround the fast-
growing barbed end of filaments and remain associated
with them. Critical domain for filament nucleation is the
FH2 domain which forms a unique “tethered dimer” with
a flexible lasso and linker structure that allows the FH2 to
“stair-step” on the barbed end while elongating the filament
[Xu et al., 2004].
ABPs in Actin Filament Growth and
Organization
Actin filament growth is regulated by a wide range of ABPs
which frequently employ WH2 domains for G-actin bind-
ing [Paunola et al., 2002], but regulate growth and branch-
ing of the actin cytoskeleton differently. While WASP feeds
actin monomers into the growing filament, polymerization
antagonists such as thymosins bind G-actin to sequester it
[Paunola et al., 2002]. Disordered thymosin b4 is mainly
expressed in neurones and oligodentdrocytes and its main
function is to bind and sequester actin monomers [Safer
et al., 1997].
Growth of the actin cytoskeleton is generally regulated
by F-actin binding proteins such as capping proteins that
control filament length or cross-linking proteins that organ-
ize the filaments into bundles or networks. These ABPs fre-
quently utilize IDRs to simultaneously interact with the
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filaments and other associated proteins (Table I). The
pointed-end-CP tropomodulin, for example, stabilizes F-
actin in myofibrils in muscle sarcomers [Kostyukova et al.,
2001; Uversky et al., 2011]. Structural studies identified a
globular C-terminal domain and an intrinsically disordered
N-terminus that contains three binding sites: two tropo-
myosin–binding sites and a tropomyosin-dependent actin-
capping site [Kostyukova et al., 2001]. The flexible actin
CP suppresses actin polymerization at the barbed end by
binding it with its so-called b-tentacle, a C-terminal region
that only forms a stable amphipathic helix when it binds to
the hydrophobic cleft of actin [Takeda et al., 2011; Zwolak
et al., 2010]. A number of proteins (CARMIL proteins)
carry a CP-binding motif in a disordered region, and are
able to inhibit CP by dramatically decreasing its affinity for
the barbed end [Uruno et al., 2006].
Intrinsically disordered domains and motifs are also fre-
quently employed by cross-linking ABPs. Intrinsically disor-
dered caldesmon, one of the most abundant proteins
detected in smooth muscle and in a number of nonmuscle
cells, has a functionally important C-terminal domain [Per-
myakov et al., 2003]. Caldesmon cross-links thick and thin
filaments by binding actin filaments and myosin [Morgan
and Gangopadhyay, 2001]. While its N-terminal part has
been described as a myosin/calmodulin-binding domain,
the C-terminus contains a tropomyosin/actin/calmodulin-
binding domain [Permyakov et al., 2003]. Myotilin, a
component of a complex of multiple actin cross-linking
proteins that belongs to the palladin family, has a
unique N-terminal IDR [Salmikangas et al., 2003]. The
protein is involved in the control of myofibril assembly
and stability at the Z lines in muscle cells and has
been implicated in muscular dystrophy [Salmikangas
et al., 2003]. Palladin itself was found to localize at
sites where active actin remodeling takes place, such as
lamellipodia [Otey et al., 2005].
A number of proteins involved in actin filament organi-
zation and nucleation play a critical role in the formation of
cellular protrusions such as filopodia and invadopodia.
Examples include the afore-mentioned cortactin and super-
villin which belongs to the villin/gelsolin family of actin-
organizing proteins [Silacci et al., 2004] which also contains
the members dematin and gelsolin that possess IDRs of
315 and 40 residues, respectively [Chen et al., 2009; Smir-
nov et al., 2007]. Supervillin has a unique, more than 800
amino acid long, intrinsically disordered N-terminus which
promotes interactions with several signaling proteins and
major cytoskeletal components, including F-actin and
human nonmuscle myosin II [Chen et al., 2003; Crowley
et al., 2009; Fedechkin et al., 2012] and it influences cyto-
kinesis, cell motility and can promote invasive activity in
tumors by formation of invadopodia or podosomes [Crow-
ley et al., 2009; Weaver, 2006]. Invadopodia and podo-
somes are actin-rich protrusions that form at sites of
extracellular matrix (ECM) degradation [Weaver, 2006];
tumor cells forming the highly active invadopodia are par-
ticularly invasive and migratory [Weaver, 2006].
Aside from regulating the polymerization and organiza-
tion of actin filaments, actin and ABPs have a variety of
other functions in endocytosis and trafficking [dos Reme-
dios et al., 2003; Mooren et al., 2012]. Several of the pro-
teins involved in endocytosis, such as dynamin, epsin, or
auxilin, interact with actin and have been reported to have
IDRs to facilitate effective vesicle formation [Dafforn and
Smith, 2004; Gu et al., 2010]. In all, intrinsic disorder is
involved in the function of most actin-regulatory proteins.
Intrinsically Disordered ABPs in
Disease and Infection
The influence of ABPs on cell mobility, signaling and traf-
ficking by small binding motifs such as the W domain is
frequently implicated in cancer and pathogens [Condeelis
et al., 2005]. Many bacterial pathogens exploit the host
Arp2/3 complex to induce actin polymerization once they
enter the host cytoplasm. Listeria monocytogenes expresses
proteins that mimic WASP family proteins but lack their
regulatory domains, for example, the IDP Listeria ActA
binds actin and promotes constitutive actin nucleation
[Footer et al., 2008]. Other proteins encoded by the patho-
gens have the ability to recruit and activate host ABPs to
influence cytoskeleton structure and dynamics. The malaria
parasite Plasmodium falciparum, for instance, remodels the
actin cytoskeleton of host cells [Gomes-Santos et al., 2012;
Radtke et al., 2006] by upregulating gelsolin, a growth reg-
ulatory ABP that prevents filament elongation [Gomes-San-
tos et al., 2012]. Pathogenic bacteria express proteins that
directly interact with the host actin cytoskeleton. The Sal-
monella invasion protein A (SipA), a virulence factor, binds
to actin and influences cytoskeletal rearrangement to pro-
mote uptake of the pathogen. SipA employs two IDRs
described as nonglobular arms that stabilize filaments by
binding actin subunits in opposing strands [Lilic et al.,
2003]. The crucial role of many ABPs is evident in the dis-
eases caused by mutations in genes encoding ABPs. For
example, the Wiskott-Aldrich syndrome, a disease caused
by mutations in the WASP gene, affects the immune sys-
tem, and entails eczema and thrombocytopenia [Binder
et al., 2006].
IDPs in the Extracellular Matrix
The ECM surrounds and connects animal cells to form tis-
sue. Consisting of the basement membrane and the intersti-
tial matrix, the ECM provides structural support for the
cell and regulates intercellular communication necessary for
wound healing, fibrosis and growth [Kim et al., 2011]. The
interstitial matrix is composed of polysaccharide gels and
fibrous proteins that serve as a buffer against mechanical
stress to the ECM and activate growth factors which allow
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the regulation of cellular functions as a consequence of
extracellular signaling [Kim et al., 2011].
Interestingly, proteins located in the ECM seem to utilize
intrinsically disordered domains more frequently than cellu-
lar proteins. Especially proteins involved in the organization
of the ECM, molecular recognition and cell-matrix adhe-
sion contain long disordered regions [Peysselon et al.,
2011]. Accordingly, the amount of amino acid residues pre-
dicted to be part of a disordered region was found to reach
57% in members of the collagen superfamily, and 97% in a
second family, the small integrin-binding ligand N-linked
glycoproteins [Peysselon et al., 2011]. The high levels of
intrinsic disorder might be necessary to provide extracellular
proteins with the structural flexibility to act as hubs for
intracellular, extracellular and membrane-bound interaction
partners in a constantly changing environment exposed to
mechanical stress [Peysselon et al., 2011].
Conclusions and Perspectives
Structural disorder is everywhere in cytoskeleton, due to the
advantages enumerated in the Introduction. Structural dis-
order is involved in multiple adaptive binding in nucleating
polymerization, in regulation by post-translational modifi-
cations, in maintaining spacing and connectivity of cytos-
keletal elements, in selectively binding multiple cargo
proteins and in general regulating the formation, mainte-
nance and rearrangements of the cytoskeleton in countless
ways. Because disordered regions can interact in an adaptive
process with several proteins, no wonder several of the
accessory proteins are involved with more than one cytos-
keletal component, that is, they mediate interaction and
cross-talk between the three major filamentous systems.
Such proteins are usually highly disordered.
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